| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.076 | 0.08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.065 | 0.2 |